Trading Concept
  • Home
  • Trading News
  • Email Whitelisting
  • Privacy Policy
  • Home
  • Trading News
  • Email Whitelisting
  • Privacy Policy
No Result
View All Result
Trading Concept
No Result
View All Result
Home Trading News

Pfizer CEO confident Covid treatment pill will be effective against omicron variant

by
November 29, 2021
in Trading News
0
0
SHARES
0
VIEWS
Share on FacebookShare on Twitter

RELATED POSTS

‘God bless Elon Musk’: Top Republican lauds Twitter owner ahead of key hearing

Adani abandons $2.5 billion share sale in big blow to Indian tycoon

Pfizer CEO Albert Bourla said Monday he expects the company’s Covid-19 treatment pill to be effective against the omicron variant of the virus causes Covid-19.

“The good news when it comes to our treatment, it was designed with that in mind, it was designed with the fact that most mutations are coming in the spikes,” Bourla told CNBC’s “Squawk Box.” “So that gives me very high level of confidence that the treatment will not be affected, our oral treatment will not be affected by this virus.”

Pfizer submitted its application earlier this month to the Food and Drug Administration to authorize the pill, Paxlovid, for emergency use. In a clinical trial of people age 18 and over, Pfizer found the pill reduces hospitalization and death by 89% when taken with a widely used HIV drug within three days of the start of symptoms.

The pill blocks an enzyme the virus needs to replicate. It is used in combination with HIV drug ritonavir, which slows the human metabolism to allow the Paxlovid to remain active in the body longer at a higher concentration to combat the virus.

Bourla told CNBC that Pfizer now expects to manufacture 80 million courses of the pill, an increase from the company’s original 50 million course manufacturing goal. The Biden administration has already bought 10 million courses of Paxlovid in a $5 billion deal.

The World Health Organization, in a technical paper published Sunday, warned that omicron poses a “very high” global risk with a high likelihood of further transmission. The variant has more than 30 mutations on the spike protein that binds to human cells. Some of the mutations are associated with higher transmission and a decrease in antibody protection, according to the WHO.

While Bourla was optimistic about the efficacy of Paxlovid, he said the impact of omicron on the company’s two-dose vaccine remains to be seen.

“I don’t think that the result will be the vaccines don’t protect,” Bourla said. “I think the result could be, which we don’t know yet, the vaccines protect less.”

Bourla said Pfizer has already begun work to manufacture a new vaccine if necessary. The company made its first DNA template on Friday, he said, the initial step in the development process.

“We have made multiple times clear that we would be able to have the vaccine in less than 100 days,” Bourla said. He noted that the company was able to create vaccines for the beta and delta variants quickly, though they ultimately weren’t used because the original shots remained effective.

ShareTweetPin

Related Posts

‘God bless Elon Musk’: Top Republican lauds Twitter owner ahead of key hearing

by
February 1, 2023
0

U.S. Rep. James Comer (R-KY), Chairman of the House Oversight and Accountability Committee, speaks at a media event at the...

Adani abandons $2.5 billion share sale in big blow to Indian tycoon

by
February 1, 2023
0

In this article ADANIENT-IN Follow your favorite stocksCREATE FREE ACCOUNT Gautam Adani, billionaire and chairman of Adani Group, during an...

Morgan Stanley analyst says these ‘undervalued’ bank stocks could rise 24%

by
February 1, 2023
0

The top picks of Morgan Stanley bank analyst Betsy Graseck are looking undervalued as the market rallies, she said Wednesday...

Here’s what the Federal Reserve’s 25 basis point interest rate hike means for your money

by
February 1, 2023
0

The Federal Reserve raised the target federal funds rate for the eighth time in a row on Wednesday, in its...

Samsung launches new Galaxy S23 smartphone lineup with improved camera, gaming capabilities

by
February 1, 2023
0

In this article SMSD-GB Follow your favorite stocksCREATE FREE ACCOUNT Samsung announced its flagship Galaxy S23 smartphone lineup on Wednesday....

Next Post

Black Knight: Number of Mortgages in Forbearance Increased Slightly

Biden says he doesn't expect more travel restrictions or lockdowns as Covid omicron variant spreads

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

email

Get the daily email about stock.

Please Enter Your Email Address:



By opting in you agree to our Privacy Policy. You also agree to receive emails from us and our affiliates. Remember that you can opt-out any time, we hate spam too!

MOST VIEWED

  • WHO says Covid vaccine booster programs will prolong pandemic

    0 shares
    Share 0 Tweet 0
  • Forget Tesla — this auto stock is the one to buy right now, analyst says

    0 shares
    Share 0 Tweet 0
  • Spin or Split? AT&T Has a Big Decision to Make on Discovery Stake.

    0 shares
    Share 0 Tweet 0
  • Here’s how Carl Icahn is positioning for a possible recession in America

    0 shares
    Share 0 Tweet 0
  • Some lawmakers and their families are betting thousands of dollars on crypto

    0 shares
    Share 0 Tweet 0
  • Home
  • Trading News
  • Email Whitelisting
  • Privacy Policy
All rights reserved by tradingconcept.net
No Result
View All Result
  • Email Whitelisting
  • Home
  • Privacy Policy

All rights reserved by www.tradingconcept.net